Quanta Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-246/24/26 | Amended | $76,192,272 | $25,506,904 | Equity Only | 06b | SEC linkSEC |
| 2023-05-255/25/23 | New | $50,685,368 | $50,685,368 | Equity Only | 06b | SEC linkSEC |
| 2023-02-172/17/23 | New | $29,999,993 | $29,999,993 | Equity Only | 06b | SEC linkSEC |
| 2021-11-0311/3/21 | New | $40,152,323 | $40,152,323 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Leonardo Faoro | Executive |
| Maria Fardis | Director |
| Arjun Goyal | Director |
| Ying Huang | Director |
| Rajul Jain | Director |
| Maha Katabi | Director |
| Derek Metzger | Executive |
| Perry Nisen | Director, Executive |
| Cameron Pitt | Director, Executive |
| Samuel Saks | Director |
Industry: Biotechnology (See others in industry)
Address:
Two Tower Place, Floor 17
South San Francisco, CA, 94080
Phone: (970) 742-4190
South San Francisco, CA, 94080
Phone: (970) 742-4190